G1 Therapeutics Inc.

NASDAQ: GTHX · Real-Time Price · USD
7.16
0.01 (0.14%)
At close: Sep 17, 2024, 9:56 PM

G1 Therapeutics Revenue

G1 Therapeutics reported an annual revenue of $82.51M, reflecting a 60.84% growth. For the quarter ending June 30, 2024, G1 Therapeutics generated $16.55M in revenue.
Revenue (ttm)
82.51M
Revenue Growth
60.84%
Price / Sales Ratio
1.91
Revenue / Employee
825.11K
Employees
100
Market Cap
377.75M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2023 82.51M +60.84%
Dec 31, 2022 51.3M +62.98%
Dec 31, 2021 31.48M -30.49%
Dec 31, 2020 45.28M +Infinity%
Dec 31, 2019 0 n/a
Dec 31, 2018 0 n/a
Dec 31, 2017 0 n/a
Dec 31, 2016 0 -100.00%
Dec 31, 2015 522K -49.94%
Dec 31, 2014 1.04M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.